Denali Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,000
| Closed | -$54K | – | 456 |
|
|
2023
Q3 | $54K | Hold |
18,000
| – | – | 0.02% | 290 |
|
|
2023
Q2 | $67.3K | Hold |
18,000
| – | – | 0.02% | 280 |
|
|
2023
Q1 | $60.3K | Hold |
18,000
| – | – | 0.03% | 206 |
|
|
2022
Q4 | $86.6K | Buy |
18,000
+13,600
| +309% | +$65.4K | 0.04% | 174 |
|
|
2022
Q3 | $25K | Buy |
+4,400
| New | +$25K | 0.01% | 269 |
|